Thermo Fisher Inks Cdx Agreement With Hengrui Therapeutics

Thermo Fisher Scientific Has Signed A Companion Diagnostic (Cdx) Agreement With Hengrui Therapeutics, Inc. (Hti), A Us Subsidiary Of Chinese Pharmaceutical Company Jiangsu Hengrui Medicine (Jhm), To Develop A Cdx That Will Leverage The Oncomine Precision Assay, Which Runs On The New Ion Torrent Genexus System. Once Commercialized, The Cdx Will Be Used To Identify Non-Small Cell Lung Cancer (Nsclc) Patients Who May Be Eligible For Pyrotinib, Jhm'S Novel, Irreversible Pan-Her2 Tyrosine Kinase Inhibitor.Under The Terms Of The Agreement, Thermo Fisher Will Retain Rights To Commercialize The Test Globally And Will Seek Approval From Regulatory Agencies. The Company Has Previously Announced A Cdx Agreement That Also Leverages The Oncomine Precision Assay For The Genexus System. In June The Fda Granted The Assay Breakthrough Device Designation To Identify Isocitrate Dehydrogenase 1 And 2 (Idh1 And Idh2) Mutations In Low-Grade Glioma Patients.The Oncomine Precision Assay Can Detect More Than 50 Cancer-Related Biomarkers From Formalin-Fixed Paraffin-Embedded (Ffpe) Tumor Tissues Or Liquid Biopsy Specimens. It Is Designed To Run On The Genexus System, A First-Of-Its-Kind Ngs Platform That Features An Automated Workflow With A One-Day Turnaround Time And The Lowest Sample Requirements On The Market For Detection Of Both Dna And Rna Variants. Currently, The Integrated Sequencer And Assay Are Labeled For Research Use Only.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!